Internal Medicine, Endocrinology, Diabetes, & Metabolism · Encinitas, CA
NPI
1144303538
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
351 Santa Fe Dr Ste 240
Encinitas, CA, 92024
Phone (858) 704-4151
Groups this clinician bills Medicare through
Medicare paid, 2024
$39K
418 services
Medicare patients, 2024
303
Average age 73
Drug cost, 2024
$1.0M
1,693 prescriptions
Company payments, 2025
$1,393
From 24 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Georges M Argoud was code 99214 (office e&m - established), 168 times for 143 patients. In total Georges M Argoud billed 418 services in 12 codes, and Medicare paid $39K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-04-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 168 | 143 | $90.37 | $15K |
| 99204 Office E&M - New | Office | 81 | 81 | $121.36 | $9,830 |
| 99443 Telephone Services | Office | 53 | 49 | $75.67 | $4,010 |
| 10005 Other Organ Systems | Office | 22 | 21 | $102.89 | $2,264 |
| 99215 Office E&M - Established | Office | 21 | 18 | $130.79 | $2,747 |
| 99203 Office E&M - New | Office | 15 | 15 | $94.63 | $1,419 |
| 99442 Telephone Services | Office | 15 | 15 | $58.91 | $884 |
| 99213 Office E&M - Established | Office | 14 | 14 | $72.61 | $1,016 |
By year: 2022 $72K for 794 services; 2023 $79K for 803 services; 2024 $39K for 418 services.
Medicare prescription drug claims, 2024
In 2024, the drug Georges M Argoud prescribed most often to Medicare patients was Levothyroxine Sodium, with 237 prescriptions and refills. In total Georges M Argoud wrote 1,693 Medicare prescriptions that cost $1.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 237 | 482 | 93 | $2,577 |
| Jardiance Empagliflozin | 176 | 246 | 62 | $142K |
| Ozempic Semaglutide | 167 | 185 | 47 | $165K |
| Alendronate Sodium Generic | 76 | 137 | 32 | $556 |
| Methimazole Generic | 65 | 119 | 26 | $582 |
| Trulicity Dulaglutide | 46 | 53 | 20 | $49K |
| Humalog Kwikpen U-100 Insulin Lispro | 40 | 90 | 26 | $5,588 |
| Metformin Hcl Generic | 38 | 64 | 12 | $212 |
| Cinacalcet Hcl Generic | 37 | 49 | 17 | $12K |
| Metformin Hcl Er Metformin Hcl | 35 | 83 | 16 | $690 |
| Hydrocortisone Generic | 32 | 37 | Under 11 | $1,036 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 31 | 72 | 12 | $3,029 |
| Mounjaro Tirzepatide | 30 | 34 | 13 | $34K |
| Prolia Denosumab | 27 | 157 | 24 | $45K |
| Calcitriol Generic | 27 | 33 | Under 11 | $304 |
Brand drugs: 837 claims; generic drugs: 817 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Georges M Argoud $1,393 ($1,393 in general payments such as food, travel and fees) from 24 companies. The largest payer was Insulet Corporation with $210.
| Company | Payments | Amount |
|---|---|---|
| Insulet Corporation PODD | 24 | $210 |
| Sanofi-Aventis U.S. LLC SNY | 8 | $139 |
| Lilly USA, LLC LLY | 8 | $133 |
| Xeris Pharmaceuticals, Inc. | 5 | $90.73 |
| Recordati_rare_diseases_inc. | 3 | $82.63 |
| Amgen Inc. AMGN | 4 | $79.51 |
| Tandem Diabetes Care, Inc. TNDM | 3 | $75.13 |
| CeQur Corporation | 1 | $67.75 |
| Dexcom, Inc. DXCM | 3 | $67.15 |
| Sequel Med Tech, LLC | 2 | $62.6 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.